Abstract
Risk of death and risk of recurrence in 108 potentially curable non-small-cell lung cancer patients were analysed with respect of TNM stage, histological type and carcinoembryonic antigen (CEA), CA125 antigen and squamous cell carcinoma antigen (SCC) levels in serum and cytosol. CA125 and CEA levels were closely related to outcome figures. Multivariate analyses indicated that TNM stage and histological type had the best predictive power, but serum and cytosolic CA125 and serum CEA contained additional, independent prognostic information. Predictive information drawn from serum and cytosolic levels proved mutually complementary. We conclude that CA125 and CEA complement TNM classification and histological type for the purpose of quantifying risk of death or recurrence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Díez, M., Torres, A., Maestro, M. et al. Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer. Br J Cancer 73, 1248–1254 (1996). https://doi.org/10.1038/bjc.1996.239
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.239
This article is cited by
-
Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer
BMC Pulmonary Medicine (2017)
-
Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer
British Journal of Cancer (2015)
-
Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer
BMC Cancer (2012)
-
Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence
British Journal of Cancer (2004)
-
Lung tumour markers in oncology practice: a study of TPA and CA125
British Journal of Cancer (2002)